Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057109336954v1
14/5/538    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by MacArthur, R.
Right arrow Articles by Auld, D. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacArthur, R.
Right arrow Articles by Auld, D. S.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Medicines
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Monitoring Compound Integrity With Cytochrome P450 Assays and qHTS

Ryan MacArthur

NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA

William Leister

NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA

Henrike Veith

NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA

Paul Shinn

NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA

Noel Southall

NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA

Christopher P. Austin

NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA

James Inglese

NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA

Douglas S. Auld

NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA, dauld{at}mail.nih.gov

The authors describe how room temperature storage of a 1120-member compound library prepared in either DMSO or in a hydrated-DMSO/water (67/33) mixture affects the reproducibility of potency values as monitored using cytochrome P450 1A2 and 2D6 isozyme assays. The bioluminescent assays showed Z' factors of 0.71 and 0.62, with 17% and 32% of the library found as active against the CYP 1A2 and 2D6 isozymes, respectively. The authors tested the library using quantitative high-throughput screening to generate potency values for every library member, which was measured at 7 time intervals spanning 37 weeks. They calculated the minimum significant ratio (MSR) from these potency values at each time interval and found that for the library stored in DMSO, the CYP 1A2 and 2D6 assay MSRs progressed from approximately 2.0 to 5.0. The hydrated conditions showed similar performance in both MSR progression and analytical quality control results. Based on this study, the authors recommend that DMSO samples be stored in 1536-well plates for <4 months at room temperature. Furthermore, the study illustrates the degree and time scale of apparent compound potency changes due to sample storage. (Journal of Biomolecular Screening 2009:538-546)

Key Words: HTS • compound storage • DMSO • quantitative HTS

This version was published on June 1, 2009

Journal of Biomolecular Screening, Vol. 14, No. 5, 538-546 (2009)
DOI: 10.1177/1087057109336954


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?